Lisa DeFrancesco | Senior Vice President, Investor Relations and Corporate Affairs |
Jerry Durso | President and CEO |
Sandip Kapadia | Chief Financial Officer |
Gail Cawkwell | SVP of Medical Affairs, Safety & PharmaCo Vigilance and Acting CMO |
Yasmeen Rahimi | Piper Sandler |
Steve Seedhouse | Raymond James |
Alethia Young | Cantor |
Aryeh Gold | Jefferies |
Navin Jacob | UBS |
Brian Skorney | Baird |
Ritu Baral | Cowen |
Michael Morabito | Chardan Capital Markets |
Brian Abrahams | RBC Capital Markets |
Joseph Stringer | Needham & Company |
Aspen Mori | Bank of America |
Jay Olson | Oppenheimer |
Matthew Luchini | BMO Capital |
Sahil Kazmi | B. Riley |
Ladies and gentlemen, thank you for standing by. And welcome to the Fourth Quarter 2020 Intercept Pharmaceutical Earnings Call [Operator Instructions]. Please be advised that today's conference may be recorded. I'd now like to hand the conference over to your host today, Ms. Lisa DeFrancesco, Senior Vice President, Investor Relations and Corporate Affairs.